Negative regulation of toll-like receptors signaling pathways

Progress in Biochemistry and Biophysics

Volumn 36, Issue 12, 2009, Pages 1516-1522

  Sun, Bing ^a   Han, Dai Shu ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Inflammation; Negative regulation; Signal transduction; Toll like receptors

Indexed keywords

EID: 77951148542     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: 10.3724/SP.J.1206.2009.00213     Document Type: Review

References (29)

1. Fischer M, Ehlers M. Toll-like receptors in autoimmunity. Ann N Y Acad Sci, 2008, 1143: 21-34
2. Wang H K, Han D S. Prog Biochem Biophys, 2006, 33(9): 820-827
3. Wang J, Hu Y, Deng W W, et al. Negative regulation of Toll-like receptor signaling pathway. Microbes Infect, 2009, 11(3): 321-327
4. O'Neill L A, Bowie A G. The family of five: TIR-domain-containing adaptors in Toll-like receptor signalling. Nat Rev Immunol, 2007, 7 (5): 353-364
5. Creagh E M, O'Neill L A. TLRs, NLRs and RLRs: a trinity of pathogen sensors that co-operate in innate immunity. Trends Immunol, 2006, 27(8): 352-357
6. Kuroishi T, Tanaka Y, Sakai A, et al. Human parotid saliva contains soluble toll-like receptor (TLR) 2 and modulates TLR2-mediated interleukin-8 production by monocytic cells. Mol Immunol, 2007, 44(8): 1969-1976 (Pubitemid 44827247)
7. Fernández-Fernández L, Bellido-Martln L, García de Frutos P. Growth arrest-specific gene 6 (GAS6). An outline of its role in haemostasis and inflammation. Thromb Haemost, 2008, 100 (4): 604-610
8. O'Neill L A. The interleukin-1 receptor/Toll-like receptor superfamily: 10 years of progress. Immunol Rev, 2008, 226(1): 10-18
9. Sweet M J, Leung B P, Kang D, et al. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-like receptor4 expression. J Immunol, 2001, 166(11): 6633-6639
10. Takezako N, Hayakawa M, Hayakawa H, et al. ST2 suppresses IL-6 production via the inhibition of DcappaB degradation induced by the LPS signal in THP-I cells. Biochem Biophys Res Commun, 2006, 341(2): 425-432
11. Divanovic S, Trompette A, Atabani S F, et al. Inhibition of TLR-4/MD-2 signaling by RP105/MD-1. J Endotoxin Res, 2005, 11 (6): 363-368
12. Lech M, Kulkami O P, Pfeiffer S, et al. Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J Exp Med, 2008, 205(8): 1879-1888
13. Hafizi S, Dahlback B. Gas6 and protein S. Vitamin K-dependent ligands for the Axl receptor tyrosine kinase subfamily. FEBS J. 2006, 273(23): 5231-5244
14. Rothlin C V, Ghosh S, Zuniga E I, et al. TAM receptors are pleiotrope inhibitors of the innate immune response. Cell, 2007, 131(6): 1124-1136 (Pubitemid 350235020)
15. Diehl G E, Yue H H, Hsieh K, et al. TRAIL-R as a negative regulator of innate immune cell responses. Immunity, 2004, 21(6): 877-889
16. Fearns C, Pan Q, Mathison J C, et al. Triad3A regulates ubiquitination and proteasomal degradation of RIPl following disruption of Hsp90 binding. J Biol Chem, 2006, 281(45): 34592-34600 (Pubitemid 46036665)
17. Mansell A, Smith R, Doyle S L, et al. Suppressor of cytokine signaling 1 negatively regulates Toll-like receptor signaling by mediating Mal degradation. Nat Immunol, 2006, 7(2): 148-155 (Pubitemid 43135880)
18. Pothlichet J, Chiqnard M, Si-Tahar M. Cutting edge: innate immune response triggered by influenza A virus is negatively regulated by SOCSl and SOCS3 through a RIG-I/IFNAR1 -dependent pathway. J Immunol, 2008, 180(4): 2034-2038
19. Saitoh T, Tun-Kyi A, Ryo A, et al. Negative regulation of interferonregulatory factor 3-dependent innate antiviral response by the prolyl isomerase Pinl. Nat Immunol, 2006, 7(6): 598-605 (Pubitemid 43797341)
20. Kameda H, Watanabe M, Bohqaki M, et al. Inhibition of NF-kappaB signaling via tyrosine phosphorylation of Ymer. Biochem Biophys Res Commun, 2009, 378(4): 744-749
21. Yoshida H, Jono H, Kai H, et al. The tumor suppressor cylindromatosis (CYLD) acts as a negative regulator for Toll-like receptor 2 signaling via negative cross-talk with TRAF6 AND TRAF7. J Biol Chem, 2005, 280(49): 41111-41121
22. Carty M, Goodbody R, Schroder M, et al. The human adaptor SARM negatively regulates adaptor protein TRIF-dependent Toll-like receptor signaling. Nat Immunol, 2006, 7(10): 1074-1081 (Pubitemid 44420652)
23. Kenny E F, O'Neill L A. Signalling adaptors used by Toll-like receptors: an update. Cytokine, 2008, 43(3): 342-349
24. Mendoza-Barbera E, Corral-Rodrlguez M A, Soares-Schanoski A, et al. Contribution of globular death domains and unstructured linkers to MyD88. IRAK-4 heterodimer formation: an explanation for the antagonistic activity of MyD88s. Biochem Biophys Res Commun, 2009, 380(1): 183-187
25. Nquyen T, De Nardo D, Masendycz P, et al. Regulation of IRAK-I activation by its C-terminal domain. Cell Signal, 2009, 21(5): 719-726
26. Whitmore M M, Iparraguirre A, Kubelka L, et al. Negative regulation of TLR-signaling pathways by activating transcription factor-3. J Immunol, 2007, 179(6): 3622-3630
27. den Dunnen J, Gringhuis S I, Geijtenbeek T B. Innate signaling by the C-type lectin DC-SIGN dictates immune responses. Cancer Immunol Immunother, 2009, 58(7): 1149-1157
28. An H, Zhao W, Hou J, et al. SHP-2 phosphatase negatively regulates the TRIF adaptor protein-dependent type I interferon and proinflammatory cytokine production. Immunity, 2006, 25 (6): 919-928
29. Shi M, Deng W, Bi E, et al. TRIM30 alpha negatively regulates TLR-mediated NF-kappa B activation by targeting TAB2 and TAB3 for degradation. Nat Immunol, 2008, 9(4): 369-377